Corporate Board Profile
Tech Score: 100/100
5 mention(s) identify DR. VINCENT OSSIPOW as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| IMMUNIC, INC. | 2019-06-18 | Dr. Ossipow trained as a postdoctoral fellow in Geneva (Hoffman-La-Roche and Human Frontier Science Program fellow) and at the National Cancer Institute in Bethesda, MD. He completed a Certificate in International Finance and Global Markets at the Georgetown University School of Business and holds an M.S. in computational sciences, an M.S. in molecular biology, and a Ph.D. in molecular biology, all from the University of Geneva. | Dr. Ossipow holds an M.S. in computational sciences, which indicates software-related technical skills and the ability to write programs. |
| IMMUNIC, INC. | 2020-04-29 | He completed a Certificate in International Finance and Global Markets at the Georgetown University School of Business and holds an M.S. in computational sciences, an M.S. in molecular biology, and a Ph.D. in molecular biology, all from the University of Geneva. | Holds an M.S. in computational sciences, indicating technical skills related to software and programming. |
| IMMUNIC, INC. | 2021-04-27 | Dr. Ossipow holds an M.S. in computational sciences, an M.S. in molecular biology, and a Ph.D. in molecular biology, all from the University of Geneva. | Dr. Ossipow holds an M.S. in computational sciences, which indicates a technical background related to software and programming. |
| IMMUNIC, INC. | 2022-04-27 | Dr. Ossipow holds an M.S. in computational sciences, an M.S. in molecular biology, and a Ph.D. in molecular biology, all from the University of Geneva. | Dr. Ossipow holds an M.S. in computational sciences, which indicates technical skills related to software and programming. |
| IMMUNIC, INC. | 2023-05-01 | Dr. Ossipow holds an M.S. in computational sciences, an M.S. in molecular biology, and a Ph.D. in molecular biology, all from the University of Geneva. | Dr. Ossipow holds an M.S. in computational sciences and has a strong scientific and technical background, indicating software-related skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2019-06-18 | Dr. Ossipow trained as a postdoctoral fellow in Geneva (Hoffman-La-Roche and Human Frontier Science Program fellow) and at the National Cancer Institute in Bethesda, MD. He completed a Certificate in International Finance and Global Markets at the Georgetown University School of Business and holds an M.S. in computational sciences, an M.S. in molecular biology, and a Ph.D. in molecular biology, all from the University of Geneva. |
| 2020-04-29 | He completed a Certificate in International Finance and Global Markets at the Georgetown University School of Business and holds an M.S. in computational sciences, an M.S. in molecular biology, and a Ph.D. in molecular biology, all from the University of Geneva. |
| 2021-04-27 | Dr. Ossipow holds an M.S. in computational sciences, an M.S. in molecular biology, and a Ph.D. in molecular biology, all from the University of Geneva. |
| 2022-04-27 | Dr. Ossipow holds an M.S. in computational sciences, an M.S. in molecular biology, and a Ph.D. in molecular biology, all from the University of Geneva. |
| 2023-05-01 | Dr. Ossipow holds an M.S. in computational sciences, an M.S. in molecular biology, and a Ph.D. in molecular biology, all from the University of Geneva. |
Data sourced from SEC filings. Last updated: 2026-02-08